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1. Introduction 
Feeding clotibrate to rats will induce a prominent 
increase in the number of peroxisomes [ 1 ] and of the 
capacity for fatty-acid oxidation [2,3]. 
Clofibrate feeding also results in a great increase in 
the hepatic content of free CoA and long-chain acyl- 
CoA [4--61 and an increase of the acylCoA hydrolase 
activity (71. 
We now report that clofibrate treatment of rats 
results in an increase of the activity of both palmitoyl- 
Lcarnitine hydrolase and palmitoylCoA hydrolase. 
Also a subcellular redistribution of the latter enzyme 
is found, possibly due to release from structurally 
changed microsomal membranes (endoplasmatic retic- 
ulum) to the particle-free supernatant. 
2. Experimental procedures 
2 .l . Rats and diets 
Male Wistar-M#ll rats (220-340 g) were randomly 
selected for control and clotibrate-treated groups, and 
given ordinary, commercial food or the same food 
containing 0.3% (w/w) clofibrate as in [4]. Both 
groups were fed lo-14 days before they were killed. 
2.2. Preparation of subcellular fractions 
The subfractions of liver homogenates were pre- 
pared essentially as in [8] with some modifications [9]. 
2.3. ultrogel AcA-44 ~hromatograph3~ and detemzina- 
tion of the app. M,- values 
The particle-free supernatant of liver was applied 
~IsevieriNorth-Holland Biomedical Press 
to a column of Ultrogel AcA44 (1.6 X 90 cm), equil- 
ibrated with IO mM Hepes buffer (pH 7.4) and 
150 mM KCl. The flow rate was 0.16 ml/min and the 
hydrolase was eluted with the same buffer. Palmitoyl- 
CoA hydrolase and decanoyl-CoA hydrolase activities 
were measured. 
2.4. Enzyme assays and other analytical methods 
HydroIysis of decanoyl-CoA, palm~toyl-CoA and 
palmitoyl-L~arnitine was assayed as in [ lo,1 l]. 
The marker enzymes were: For the outer mito- 
chondrial membrane, amine oxidase and ATP-depen- 
dent long-chain acyl-CoA synthetase (using oleate as 
the substrate) [ 12,131; for the inner mitochondrial 
membrane, carnitine palmitoyltransferase [141; for 
the mitochondrial matrix, glutamate dehydrogenase 
[ 151; for the light mitochondrial fraction, acid phos- 
phatase (lysosomes) [ 161 and catalase (peroxisomes) 
[ 171; for the microsomal fraction NADPH-cyto- 
chrome c reductase [ 181; and for the plasma mem- 
branes phosphodiesterase I [ 191. 
Fatty acid synthetase [20] and the partial reactions 
of the multi-enzyme complex, ketoreductase [21], 
were assayed as in [2021]. Protein was determined 
using the Folin-Ciocalteu reagent [22]. 
2.5 . Materials 
[ 1 -r4C] PalmitoylCoA and [ 1 -14C] palmitoyl-lcar- 
nitine were purchased from New England Nuclear, 
Boston, MA. Malonyl-CoA and N-acetylS-acetoacetyl- 
cysteamine were purchased from Sigma Chemical Co., 
St Louis, MO. Ultrogel AcA44 was from LKB, 
Bromma. Other reagents were as in [4,23,24]. 
43 
Volume 124, number 1 FEBS LETTERS February 1981 
3. Results and discussion 
Feeding clofibrate to rats resulted in an increase 
in wet liver weight from 11.6 + 0.2 g (n = 7) to 
13.4 + 0.2 g (n = 5), representing 5.4 f 0.4% of the 
body weight in treated rats and 4.2 f 0.6% in controls. 
The body weight of the rats did not change. 
The subcellular distribution of palmitoylCoA 
hydrolase, palmitoyl-L-carnitine hydrolase and differ- 
ent marker enzymes in control and clofibrate-treated 
rats is shown in table 1. The distribution pattern of 
the marker enzymes was roughly the same in the two 
groups. The recovery of enzymes and the protein was 
in the range 80-l 10%. 
In both groups, the protein content was evenly 
increased in all cellular subfractions. The marker 
enzymes (see section 2.4 above) for inner mitochon- 
drial membrane [ 141, mitochondrial matrix [ 151, 
lysosomes [ 161, peroxisomes [ 171, microsomes [ 181, 
and plasma membrane [ 191 were distributed as might 
be expected [4,11]. The cross-contamination between 
fractions, calculated from the marker enzymes, was 
low except for the presence of marker enzymes for 
the mitochondrial outer membrane, peroxisomes and 
Table 1 
Distribution of palmitoylCoA hydrolase, palmitoyl-L-carnitine hydrolase and marker enzymes in subfractions of rat liver homog- 
enates fed a normal diet us fed a diet containing clofibrate 
N 
14.1 + 1.3 
14.3 + 3.0 
% 
Pahnitoyl- CoA 
hydrolase 
Palmitoyl-Lcar- 
nitine hydrolase 
Long-chain acylCoA 
synthetase 
Carnitine palmitoyl- 
transferase 
Phosphodiesterase I 
44.1 * 1.8 
94.9 !I 19.1 
11.5 f 0.9 
20.9 * 4.0 
40.0? 10.5 
68.1 t 9.7 
9.9 i 3.2 
28.4 * 6.3 
261.7 * 15.2 
253.3 f 75.4 
9.4 * 2.3 
12.1 + 2.1 
1265 f 152 
1834 * 250 
85.2+ 11.1 
97.1 + 2.3 
103.1 * 2.3 
153.8 i 11.1 
33.2 * 12.8 
37.8 * 12.4 
11.3 f 5.2 
20.2 f 3.8 
2088 + 225 
2456 f 300 
96-110 
95-109 
94-103 
93- 98 
80- 93 
80- 92 
98-105 
97-106 
96-103 
97-105 
Amine oxidase 95- 99 
86- 96 
Glutamate dehydrog- 
enase 
Acid phosphatase 
M L P S 
20.6 2 0.9 6.7 c 2.2 54.3 f 5.8 15.2 f 5.1 
19.2 * 2.2 5.8 * 0.4 27.8 + 2.5 42.3 + 8.4 
13.9 f 3.6 7.2 f 1.2 3.6 + 1.3 56.4 t 3.6 13.2 f 4.0 
15.6 + 1.3 9.2 * 0.8 2.8 * 0.9 50.2 + 0.5 15.2 f 0.5 
17.6 + 2.3 21.9 f 8.2 4.8 f 1.6 38.6 f 7.3 15.6 f 8.6 
16.2 + 1.8 20.8 * 5.3 7.1 f 2.4 31.4 + 6.5 17.4 f 7.3 
18.0 f 3.1 62.5 + 4.1 6.4 f 2.1 10.3 r 3.2 3.4 f 0.7 
19.4 i 2.8 61.8 _+ 3.1 7.1 r 1.8 7.5 * 2.8 4.0 t 0.9 
50.2 + 9.1 13.1 + 2.1 7.0 * 0.8 24.8 r 1.0 2.1 * 0.2 
54.2 f 7.7 14.2 + 0.8 9.1 + 4.1 23.6 r 0.8 2.3 r 0.3 
18.3 + 3.5 52.9 f 2.0 8.8 + 1.0 11.5 * 0.7 3.7 f 0.5 
15.7 ? 4.0 46.4 * 1.0 9.6 ? 0.8 9.4 * 2.1 4.6 c 0.5 
22.2 f 2.3 67.8 f 2.5 7.6 * 0.5 8.0 c 3.2 0.7 * 0.4 
18.5 + 3.4 61.0 ?: 2.4 6.3 ? 1.0 2.2 2 0.6 2.0 f 0.3 
10.6 f 3.8 26.8 f 6.8 24.1 f 1.5 30.9 * 2.6 18.3 * 5.9 
10.0 f 3.4 28.0 f 3.3 33.3 + 1.1 12.1 * 2.4 18.5 + 1.8 
3.3 f 0.8 13.8 + 1.8 25.8 ? 3.2 11.8 * 3.1 48.8 * 4.0 
6.1 f 0.3 17.3 + 2.5 26.0 + 2.8 8.9 f 2.8 42.9 f 6.0 
9.9 f 3.1 5.0 f 1.1 6.1 + 5.0 49.4 ? 6.6 23.3 + 7.3 
20.3 f 0.7 5.6 fr 0.5 7.3 * 1.2 42.4 * 5.4 18.8 2 7.2 
0.2 f 0.1 10.1 f 2.3 2.5 f 1.3 0.2 * 0.1 83.4 * 4.2 
0.2 ? 0.1 12.7 f 3.2 3.5 f 0.8 0.2 ? 0.1 80.7 i- 2.8 
17.4 + 1.3 20.4 f 0.9 5.4 + 0.7 20.9 ? 2.1 34.4 * 2.8 
15.9 ? 3.0 18.5 f 2.2 6.4 + 0.4 18.1 + 2.1 32.2 f 1.7 
- 
The absolute values for enzyme activities are given in rmol mm-‘, except for carnitine palmitoyltransferase, which activity is 
given in arbitrary units. Protein is given in mg. The enzyme activities and the protein content in the subfractions are expressed as 
percent of the total in whole homogenate (i.e., cytoplasmic extract + nuclear fraction). The % values are given as the means + SD 
of 4 animals. The upper row for each enzyme represents normal fed, and the lower row clofibrate fed rats. For identification of 
the fractions, see fig.1. 
855 99 
86- 96 
98-l 10 
96-102 
Catalase 102-110 
loo-108 
NADPHcyto- 
chrome c reductase 
Keto-reductase 
94-103 
94-102 
97-106 
98-107 
Protein 96-108 
92-110 
Absolute values 
in homogenate 
Percentage values 
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microsomes in the particle-free supernatant. The dis- 
tribution of amine oxidase and longchain acyl-CoA 
synthetase, an enzyme probably also localized to the 
peroxisomes [25], might indicate some fragmentation 
of the outer mitochondrial membrane and the peroxi- 
somes. The high catalase activity found in the particle- 
free supernatant might, however, be due to ‘soluble’ 
catalase which is higher in male rats [26]. 
The palmitoyl-Lcarnitine hydrolase was localized 
in the microsomal fraction (table 1, fig.1) both in 
clofibrate-treated and control rats, confirming earlier 
findings [ 11,271. Clotibrate treatment induced an 
increase of its specific activity, in the total homoge- 
nate of 1.9-times (p < 0.001) in the microsomal frac- 
tion by -1.6-times @ < O.Ol), but not in the other 
fractions. 
Table 1 and fig.1 confirm the dual localization of 
palmitoyl-CoA hydrolase [ Ill. However, palmitoyl- 
CoA hydrolase was redistributed after clofibrate treat- 
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Fig.1. Distribution pattern of palmitoylCoA hydrolase (---) 
and palmitoyl-Lcarnitine hydrolase (-) in livers from 2 
normal and 2 clofibrate-treated rats related to the ratio 
between liver weight and body weight of the animals. The 
relative specific activity (% total activity/% total protein) is 
plotted against the relative protein content in each fraction 
(%): N, the nuclear fraction; M, the mitochondrial fraction; 
L, the light mitochondrial fraction; P, the microsomal frac- 
tion; S, the particle-free supernatant. 
4’30 40 50 60 
9 IIer/g rat wetght (%) 
Fig.2. The relative specific activity of palmitoylCoA hydro- 
lase in the microsomal fraction and the particle-free superna- 
tant in normal and clofibrate-treated rats. The relative specific 
activity of palmitoylCoA hydrolase in microsomal fraction 
(open symbols) and particle-free supernatant (filled symbols) 
of livers of rats fed a normal diet (circles) and in clofibrate- 
treated rats (triangles). 
ment (table 1, fig.l), as its activity increased in the 
particle-free supernatant, but decreased in the micro- 
somal fraction. The increase in the particle-free super- 
natant was, however, most pronounced in rats with 
the greatest liver weight gain (fig.1). In clofibrate- 
treated rats, but not in control rats, the relative spe- 
cific activities in the particle-free supernatant and in 
the microsomal fraction increased and decreased, 
respectively, in relation to the increased liver/body 
weight ratio (fig.2). 
The specific activity of palmitoylCoA hydrolase 
in the particle-free supernatant increased G-times 
O;< 0.001) after clofibrate treatment, and in the total 
homogenate and in the mitochondrial fraction 1 S--1.7- 
times (p < 0.0 1). No significant differences were 
found in the other fractions. 
In the total homogenates, the specific activities of 
longchain acyl-CoA synthetase (using oleate as sub- 
strate) and carnitine palmitoyltransferase increased 
-1.5- and 2.5-times, respectively, following clofibrate 
treatment, in agreement with [28,29]. The specific 
activities of fatty acid synthetase (not shown) and 
ketoreductase increased 2-3-times (table 1). The 
increased specific activity of catalase after clotibrate 
treatment, is in agreement with [4]. Glutamate dehy- 
drogenase activity was increased -25% in clofibrate 
treated rats (table 1). 
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The increased palmitoyl~oA hydrolysis in the par- 
ticle-free supernatant (table 1, fig.1 ,fig.2) might be 
derived from microsomes, structurally changed by 
clofibrate. This microsomal hydrolase may be partly 
soluble 1231 and localized in microsomal membrane 
fragrnents different from those containing NADPH- 
cytochrome c reductase which showed the same dis- 
tribution in the two groups (table 1). The contribu- 
tion of the mitochondrial matrix palmitoyl-CoA 
hydrolase activity [24] to the activity in the particle- 
free supernatant was probably low as the recovery of 
glutamate dehydrogenase was low in this fraction 
(table 1). Since the recovery of catalase and acid phos- 
phatase in the particle-free supernatant was about the 
same in the two groups (table l), it seems unlikely 
that the whole increase of palmitoyl-CoA hydrolase 
activity in the particle-free supernatant from clofibrate 
treated rats was derived from the peroxisomes, which 
contain acyl-CoA hydrolase activity [30]. However, 
some contribution might occur as the recovery in the 
light mitochondrial fraction was decreased (table 1) 
and the relative specific activity of the pa~mitoyl-CoA 
hydrolase decreased in the L-fraction (fig.1). 
When particle-free supernatant, both from control 
and clo~brate-treated rats, was chromatographed on 
Ultrogel AcA44 (see section 2.3 above), the palmi- 
toylCoA hydrolase activity eluted as 3 peaks (I,II,III) 
in both groups (not shown). Clofibrate administration 
thus seemed not to induce the synthesis of a new 
cytosolic acyl-CoA hydrolase. Peak I coincided with 
the void volume and contained ketoreductase activity 
and probably represented the palmitoyl-CoA hydro- 
lase activity associated with the fatty acid synthetase 
complex [3 11. The recovery of palmitoyl~oA hydro- 
lase activity after gel ~ltration was low, S--IO%, in 
agreement with [32,33]. 
When the particle-free supernatant from the clofi- 
brate treated rats was extracted by water-saturated 
butanol as in [23], and applied to the Ultrogel AcA44 
column, the palmitoyl-CoA hydrolase activity eluted 
mainly as peak II and III with a recovery of go-90%. 
The purified microsomal palmitoyl-CoA hydrolase 
[23] eluated only as peak II (not shown), 
In summary, the results indicate that the main 
increase of palmitoyl-CoA hydrolase in the particle- 
free supernatant after clofibrate treatment is due to 
drug-induced alterations of the endoplasmic reticulum. 
Also, the particle-free supernatant of rat liver possesed 
2 or 3 different palmitoyl-CoA hydrolases, one of 
which (peak I) may be a part of the fatty acid synthe- 
46 
tase complex. The enzyme found in peak iI seemed to 
be ‘microsome associated’ [23,34]. The enzyme in 
peak III possibly is a lower Mr form of the peak-11 
enzyme in [32,33]. 
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